NASDAQ: TCRX
Tscan Therapeutics Inc Stock Ownership - Who owns Tscan Therapeutics?

Insider buying vs selling

Have Tscan Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Lynx1 Capital Management LP10% Owner2025-12-236,232$0.90
$5.60kBuy
Lynx1 Capital Management LP10% Owner2025-12-2275,500$0.90
$67.95kBuy
Lynx1 Capital Management LP10% Owner2025-12-1980,069$0.90
$71.98kBuy

1 of 1

TCRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TCRX insiders and whales buy or sell their stock.

TCRX Shareholders

What type of owners hold Tscan Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Lynx1 Capital Management LP11.83%8,019,148$2.57MInsider
Ecor1 Capital LLC7.38%5,000,000$1.60MInsider
Baker Bros Advisors LP3.73%2,528,583$809.15kInsider
Christoph H. Westphal1.53%1,036,585$331.71kInsider
David P. Southwell0.25%171,569$54.90kInsider
Timothy J. Barberich0.15%100,286$32.09kInsider
Barbara Klencke0.10%70,000$22.40kInsider
Gavin MacBeath0.07%49,767$15.93kInsider
Brian M. Silver0.05%32,885$10.52kInsider
Lynx1 Capital Management LP0.01%8,019$2.57kInstitution

1 of 3

TCRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TCRX0.05%25.11%Net Buying
NEUP0.03%99.97%Net Buying
GTBP0.12%66.85%
JSPR0.02%99.98%Net Buying
KRSA0.02%99.98%Net BuyingNet Buying

Tscan Therapeutics Stock Ownership FAQ

Who owns Tscan Therapeutics?

Tscan Therapeutics (NASDAQ: TCRX) is owned by 0.05% institutional shareholders, 25.11% Tscan Therapeutics insiders, and 74.83% retail investors. Lynx1 Capital Management LP is the largest individual Tscan Therapeutics shareholder, owning 8.02M shares representing 11.83% of the company. Lynx1 Capital Management LP's Tscan Therapeutics shares are currently valued at $2.45M.

If you're new to stock investing, here's how to buy Tscan Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.